HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

FDA Releases Draft Guidance on RWD in Pharma Submissions

The Food and Drug Administration (FDA) has released its draft guidance on real world data (RWD). The guidance is intended to support submissions that incorporate data from electronic health records (EHRs) and medical claims data. The document highlights data sources, successfully capturing and […]

more info 10/19/2021View Related Articles
Bookmark and Share

Data Expert Discusses 9 RWE Applications in Healthcare and Pharma R&D

Vice President of Business Development & Real World Evidence (RWE) at ArborMetrix Benjamin Echeazu discusses the growing use of RWE in a wide range of applications—from drug development to tangibly improving patient outcomes. He details nine use cases where RWE and real world data (RWD) informed […]

more info 10/19/2021View Related Articles
Bookmark and Share

ISPOR Seeks Comments for FDA Guidance on RWD

The International Society for Pharmacoeconomics and Outcomes (ISPOR) is seeking comments for a draft guidance document published by the Food and Drug Administration (FDA) detailing how to select appropriate real world data (RWD) sources. The comment period closes in early November. “The survey […]

more info 10/14/2021View Related Articles
Bookmark and Share

Syntropy and UCI Unite in 5-Year RWD Collaboration to Improve Patient Outcomes

Syntropy and the University of California, Irvine (UCI) will collaborate in a five-year partnership intended to directly improve patient outcomes using real world data (RWD). RWD sources, such as patient-recorded data and clinical records, will be securely shared and analyzed. UCI’s Vice […]

more info 10/13/2021View Related Articles
Bookmark and Share

Syapse Announces RWD Partnership with Merck to Accelerate Oncology Research and Improve Patient Outcomes

Real world evidence (RWE) leader Syapse has announced a partnership with Merck. Together, the companies will utilize real world data (RWD) to understand the outcomes of patients living with cancer and improve care. The companies will leverage clinical, outcomes, and molecular data using the Syapse […]

more info 10/08/2021View Related Articles
Bookmark and Share

Aetion eBook Highlights the Impact of RWE in Successful Drug Approvals Ahead of FDA Framework

Aetion has published an eBook detailing how real world data (RWD) and real world evidence (RWE) can impact drug approvals by the Food and Drug Administration (FDA). The eBook includes case studies where RWE led to the approval of drugs and biologics. The guide also compares RWE use in 10 areas of […]

more info 10/08/2021View Related Articles
Bookmark and Share

Part 2 of Aetion’s ICPE Research Spotlight Highlights RWD in COVID-19 Research and Updated RWE Guidance

According to Aetion, key highlights of the August ICPE All Access Meeting hosted by the International Society for Pharmacology (ISPE) include successfully using fit-for-purpose real world data (RWD) to understand the impact of COVID-19. Other major topics included comparisons between real world […]

more info 10/08/2021View Related Articles
Bookmark and Share

Quantitative Scientist Discusses Considerations for HTAs Using RWD

Dr. Philani Brian Mpofu discusses important considerations for health technology assessments (HTAs) using real world data (RWD) to understand drug efficacy. He highlights the intricacies of RWD studies using a fictional drug, vidumab, manufactured by the fictional company Eland Pharma. “After […]

more info 10/06/2021View Related Articles
Bookmark and Share

Syneos Health Executive VP and Data Expert Discusses RWE and Aetion Collaboration

Executive Vice President of Real World Evidence (RWE) and Late Phase at Syneos Health Javier Jimenez discusses major industry trends and his organization’s recent partnership with Aetion. RWE can be used throughout the drug development pipeline to improve patient outcomes. “We can empower market […]

more info 10/06/2021View Related Articles
Bookmark and Share

Interview With RWE Expert on Expectations for FDA Framework

In a recent interview with The Evidence Base, real world evidence (RWE) expert Sreeram Ramagopalan shared his thoughts on the changing RWE landscape. He also discussed what the Food and Drug Administration (FDA) will—and won’t—include in its upcoming RWE guidelines. “Our expert for this […]

more info 10/01/2021View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Assistant Director - Oncology Strategy & Communications (Remote)
  • Senior Director - Evidence Generation & Value Communications (Remote)
  • Medical Writer
  • Senior Biostatistician, Statistical Analytics
  • Senior Director, Evidence Synthesis
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists